Substantial Decrease in Comorbidity 5 Years After Gastric Bypass
Magnus Sundbom, Jakob Hedberg, Richard Marsk et al. · Annals of Surgery · 2016
OBJECTIVE: To evaluate effect on comorbid disease and weight loss 5 years after Roux-en-Y gastric bypass (RYGB) surgery for morbid obesity in a large nationwide cohort. BACKGROUND: The number patients having surgical procedures to treat obesity and obesity-related disease are increasing. Yet, population-based, long-term outcome studies are few. METHODS: Data on 26,119 individuals [75.8% women, 41.0 years, and body mass index (BMI) 42.8 kg/m] undergoing primary RYGB between May 1, 2007 and June 30, 2012, were collected from 2 Swedish quality registries: Scandinavian Obesity Surgery Registry and the Prescribed Drug Registry. Weight, remission of type 2 diabetes mellitus, hypertension, dyslipidemia, depression, and sleep apnea, and changes in corresponding laboratory data were studied. Five-year follow-up was 100% (9774 eligible individuals) for comorbid diseases. RESULTS: BMI decreased from 42.8 ± 5.5 to 31.2 ± 5.5 kg/m at 5 years, corresponding to 27.7% reduction in total body weight. Prevalence of type 2 diabetes mellitus (15.5%-5.9%), hypertension (29.7%-19.5%), dyslipidemia (14.0%-6.8%), and sleep apnea (9.6%-2.6%) was reduced. Greater weight loss was a positive prognostic factor, whereas increasing age or BMI at baseline was a negative prognostic factor for remission. The use of antidepressants increased (24.1%-27.5%). Laboratory status was improved, for example, fasting glucose and glycated hemoglobin decreased from 6.1 to 5.4 mmol/mol and 41.8% to 37.7%, respectively. CONCLUSIONS: In this nationwide study, gastric bypass resulted in large improvements in obesity-related comorbid disease and sustained weight loss over a 5-year period. The increased use of antidepressants warrants further investigation.
Cited by 98 works. doi:10.1097/sla.0000000000001920 Open-access PDF
Authors
- Magnus Sundbom
- Jakob Hedberg
- Richard Marsk
- Lars Boman
- Ami Bylund
- Jan Hedenbro
- Anna Laurenius
- Göran Lundegårdh
- Peter Möller
- Torsten Olbers
- Johan Ottosson
- Ingmar Näslund
- Erik B. Näslund
References
- Bariatric Surgery
- Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
- Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
- Waist circumference and not body mass index explains obesity-related health risk
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
- How Do We Define Cure of Diabetes?
- Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications
- Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials
- Weight Change and Health Outcomes at 3 Years After Bariatric Surgery Among Individuals With Severe Obesity
- Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects